Literature DB >> 31153587

Prognostic significance of resident CD103+CD8+T cells in human colorectal cancer tissues.

Wenwei Hu1, Runzi Sun2, Lujun Chen2, Xiao Zheng2, Jingting Jiang3.   

Abstract

The prognostic significance and clinical implications of resident CD103+CD8+T cells in human colorectal cancer tissues still remains largely unexplored. In our present study, we aimed to characterize the resident CD8+T cells in human colorectal cancer tissues by using double staining of CD103 and CD8, and further evaluated the prognostic significance of resident CD8+T cells in colorectal cancer. We found that the OS rate of the colorectal cancer patients with higher infiltration of CD8+T cells, or with higher numbers of resident CD103+CD8+T cells, or with higher ratio of CD103+CD8+T cells over total CD8+T cells in cancer tissues was significantly better than that of the patients with lower infiltration of CD8+T cells, or with lower numbers of resident CD103+CD8+T cells, or with higher ratio of CD103+CD8+T cells over total CD8+T cells in cancer tissues, respectively. Moreover, higher infiltration of CD8+T cells in colorectal cancer tissues was significantly and inversely correlated with advanced TNM stage. Higher numbers of resident CD103+CD8+T cells in colorectal cancer tissues were significantly and inversely correlated with distant metastasis status. Higher ratio of CD103+CD8+T cells over total CD8+T cells in colorectal cancer tissues was significantly and inversely correlated with age status. The COX model analysis demonstrated that higher infiltration of CD8+T cells, higher numbers of resident CD103+CD8+T cells, or higher ratio of CD103+CD8+T cells over total CD8+T cells in colorectal cancer tissues, could serve as independent prognostic predictors for colorectal cancer patients. Taken together, our present study demonstrated the density of tumor infiltrating CD8+T cells or the numbers of resident CD103+CD8+T cells in colorectal tissues could be used as an important prognostic predictor for this malignancy.
Copyright © 2019. Published by Elsevier GmbH.

Entities:  

Keywords:  Colorectal cancer; Overall survival; Resident CD8(+)T cells; Tumor-infiltrating lymphocytes

Mesh:

Substances:

Year:  2019        PMID: 31153587     DOI: 10.1016/j.acthis.2019.05.009

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  10 in total

1.  Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells.

Authors:  Ilkka Liikanen; Colette Lauhan; Sara Quon; Kyla Omilusik; Anthony T Phan; Laura Barceló Bartrolí; Amir Ferry; John Goulding; Joyce Chen; James P Scott-Browne; Jason T Yustein; Nicole E Scharping; Deborah A Witherden; Ananda W Goldrath
Journal:  J Clin Invest       Date:  2021-04-01       Impact factor: 14.808

Review 2.  Association of CD103+ T cell infiltration with overall survival in solid tumors of the digestive tract and its potential in anti-PD-1 treatment: A review and meta-analysis.

Authors:  Wei Wei; Yun Ding; Jiajia He; Jun Wu
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2022-03-28       Impact factor: 1.245

3.  A Fraction of CD8+ T Cells from Colorectal Liver Metastases Preferentially Repopulate Autologous Patient-Derived Xenograft Tumors as Tissue-Resident Memory T Cells.

Authors:  Frank Liang; Lisa M Nilsson; Fabian Byvald; Azar Rezapour; Helena Taflin; Jonas A Nilsson; Ulf Yrlid
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

Review 4.  Tissue-resident memory T cells in breast cancer control and immunotherapy responses.

Authors:  Ann Byrne; Peter Savas; Sneha Sant; Ran Li; Balaji Virassamy; Stephen J Luen; Paul A Beavis; Laura K Mackay; Paul J Neeson; Sherene Loi
Journal:  Nat Rev Clin Oncol       Date:  2020-02-28       Impact factor: 66.675

Review 5.  Tumor-infiltrating lymphocytes in the immunotherapy era.

Authors:  Sterre T Paijens; Annegé Vledder; Marco de Bruyn; Hans W Nijman
Journal:  Cell Mol Immunol       Date:  2020-11-02       Impact factor: 11.530

Review 6.  Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time?

Authors:  Syrine Abdeljaoued; Sara Arfa; Marie Kroemer; Myriam Ben Khelil; Angélique Vienot; Bruno Heyd; Romain Loyon; Alexandre Doussot; Christophe Borg
Journal:  J Immunother Cancer       Date:  2022-04       Impact factor: 12.469

7.  POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer.

Authors:  Zhen Wu; Yue-Ming Wang; Yu Dai; Liang-An Chen
Journal:  Med Sci Monit       Date:  2020-04-18

8.  Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade.

Authors:  Romain Banchereau; Avantika S Chitre; Alexis Scherl; Thomas D Wu; Namrata S Patil; Sanjeev Mariathasan; Jane Grogan; William E O'Gorman; Patricia de Almeida; Edward E Kadel Iii; Shravan Madireddi; Amelia Au-Yeung; Chikara Takahashi; Ying-Jiun Chen; Zora Modrusan; Jacqueline McBride; Rhea Nersesian; Ehab A El-Gabry; Mark D Robida; Jeffrey C Hung; Marcin Kowanetz; Wei Zou; Mark McCleland; Patrick Caplazi; Shadi Toghi Eshgi; Hartmut Koeppen; Priti S Hegde; Ira Mellman; W Rodney Mathews; Thomas Powles
Journal:  J Immunother Cancer       Date:  2021-04       Impact factor: 13.751

9.  KCNJ14 knockdown significantly inhibited the proliferation and migration of colorectal cells.

Authors:  Bin Li; Ning Ge; Zhongping Pan; Chaofeng Hou; Kun Xie; Dongfang Wang; Junwei Liu; Jie Wan; Feihong Deng; Mengyi Li; Shuping Luo
Journal:  BMC Med Genomics       Date:  2022-09-13       Impact factor: 3.622

Review 10.  Integrin αE(CD103)β7 in Epithelial Cancer.

Authors:  Johanna C Hoffmann; Michael P Schön
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.